Pharmaceutical Quality at J&J Goes Under the Spotlight
11:05 AM | August 2, 2011 | Girish Malhotra
A recent report by a committee comprised of Johnson & Johnson (J&J) board directors essentially gives J&J a clean bill of health for a series of incidents relating to McNeil OTC. I have not reviewed...
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.